Leeds's St James's University Hospital, one of Europe's largest cancer centres, manages substantial myeloma patient volumes requiring this proteasome inhibitor. Bortenat 3.5mg provides the same treatment at significantly reduced cost.
Leeds oncologists increasingly use subcutaneous administration, producing equivalent efficacy with lower neuropathy rates than IV. Standard dosing is combined with dexamethasone and Lenalidomide or Cyclophosphamide.
FAQ: How many cycles of Bortenat treatment are typically needed for myeloma?
Treatment duration varies by individual response and treatment goal, but typically ranges from 4-8 cycles for induction therapy before stem cell transplant, or longer for ongoing treatment in relapsed disease. Your haematologist will determine the appropriate duration based on your response assessments and overall treatment plan.
